Nurse vs doctor treatment for drug-resistant tuberculosis
Part of Immune system & allergy, Infections clinical trials.
This trial compares a nurse-led plan versus a physician-led plan for treating new drug-resistant TB patients using an outpatient clinic approach. It may help by showing which care style works best and is safest for patients starting treatment close to home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older with a new diagnosis of drug-resistant TB (RR-TB)
- Be able to give informed consent in one of these languages: Zulu, Xhosa, Afrikaans, or English
- Be willing and able to start care as an outpatient (not needing urgent hospital admission)
- No serious anemia or significant liver problems (tests must be above cutoff values)
- Your heart test and heart rhythm must be within limits (no prolonged QTc or very fast heart rate after resting)
- Not be pregnant and not have disease outside the lungs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
This trial studies a treatment plan for people who have both drug-resistant tuberculosis (TB) and HIV. It focuses on starting a specific TB medication (bedaquiline) and, if needed, HIV treatment soon after enrollment to see what approach works best.
This trial tests whether adding dedicated nursing support in and out of the hospital helps people with tuberculosis complete their treatment and recover better.
This study looks at how to improve TB prevention in rural and semi-urban clinics in South Africa. They will work with clinic staff and district leaders to find better ways to stop TB.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests whether providing tuberculosis preventive treatment at home, instead of at a clinic, can help protect children under 15 who live with an adult who has recently been diagnosed with pulmonary TB. The goal is to make it easier for families to access care and stop TB from spreading.
Hear when a new Drug-resistant Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.